5 - Year: 0.715
Ranking & Category
- 239th of 261 in Pharmacology & Pharmacy
Aims & Scope
Current Pharmaceutical Analysis publishes expert reviews and original research articles on all the most recent advances in pharmaceutical and biomedical analysis. All aspects of the field are represented including drug analysis, analytical methodology and instrumentation. The journal is essential to all involved in pharmaceutical, biochemical and clinical analysis.
Biochemistry & Biophysics Citation Index®, Cabell's Directory, Cambridge Scientific Abstracts (CSA)/ProQuest, Chemical Abstracts Service/SciFinder, ChemWeb, CNKI Scholar, Dimensions, EBSCO, EMBASE, EMBiology, ERA 2018, Genamics JournalSeek, Google Scholar, InCites, Index Copernicus, Index to Scientific Reviews®, ISI Alerting Service, J-Gate, Journal Citation Reports/Science Edition, JournalTOCs, MediaFinder®-Standard Periodical Directory, Open Abstracts (I4OA), PubsHub, QOAM, Science Citation Index Expanded™ (SciSearch®), Scilit, Scopus, Suweco CZ, TOC Premier, and Ulrich's Periodicals Directory.
As a special promotion to our authors, there will be a 50% waiver on Page charges on the submission of research articles, between 1st July and 30th September 2022. This will be a saving of US$325 on the article processing charges (APC) if authors wish to publish research articles in this journal.
"It is a great privilege for Pharmaceutical and Biomedical scientists to access convincing and state-of-the-art reviews through Current Pharmaceutical Analysis."
Johnson & Johnson Pharmaceutical R&D, Belgium
(Institute of Clinical Pharmacology, Qi Lu Hospital of Shandong University, Jinan, China.)
Has contributed: The Development and Validation of the Accurate and Sensitive HPLC Method for Quantification of Mizoribine in Human Plasma and Its Clinical Applications.: